Interleukin-2 Receptor as a Marker of Oxidative Stress in Paediatric Patients with Chronic Kidney Disease or Hypertension

Interleukin-2 Receptor as a Marker of Oxidative Stress in Paediatric Patients with Chronic Kidney Disease or Hypertension

<b>Background/Objectives</b>: Oxidative stress and systemic inflammation are significant contributors to the development and progression of cardiovascular disease, causing adverse effects on vascular health and atherosclerosis from an early age. Patients with established cardiovascular r...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nataša Marčun Varda, Mirjam Močnik, Martina Filipič, Evgenija Homšak, Mateja Svetej, Sonja Golob Jančič
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Children
Subjects:	inflammation cardiovascular risk children interleukin-2 receptor
Online Access:	https://www.mdpi.com/2227-9067/12/5/569
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating the Humoral Immunity and Interleukin 18 Receptor 1 in some Patients with Molluscum Contagiosum Infection
by: Baghdad Science Journal
Published: (2016-03-01)

A ROLE FOR INTERLEUKIN 8 IN DIRECT REGULATION OF T CELL FUNCTIONAL ACTIVITY
by: M. E. Meniailo, et al.
Published: (2017-10-01)

The association of genetic polymorphisms in interleukin-1 receptors type 1 and type 2 with sudden sensorineural hearing loss in a Taiwanese population: a case control study
by: Chen-Yu Chien, et al.
Published: (2021-12-01)

Expression of tumor necrosis factor-alpha receptor 2 and interleukin-1 in middle ear cholesteatoma
by: Vranješ Dalibor, et al.
Published: (2021-01-01)

Interleukin 6 receptor inhibitors in the treatment of rheumatoid arthritis during the COVID-19 pandemic, Moscow experience
by: A. I. Zagrebneva, et al.
Published: (2022-12-01)

Independent role of interleukin interleukin-6 and interleukin-8 in the etiology of transfusion reactions to platelet concentrates in children
by: Šerbić-Nonković Olivera, et al.
Published: (2018-01-01)

Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
by: Chun-Chun Chang, et al.
Published: (2020-01-01)

Colorectal carcinoma: Evaluation of systemic values of interleukin-1 and interleukin-33 in patients with and without thrombocytosis
by: Jocić Miodrag, et al.
Published: (2021-01-01)

SECRETION OF IL-12, IL-27 BY MONONUCLEAR LEUKOCYTES AND EXPRESSION OF THEIR RECEPTORS ON T-LYMPHOCYTES IN CONDITIONS OF DIRECTED CELL INDUCTION IN VITRO IN PULMONARY TUBERCULOSIS
by: I. E. Esimova, et al.
Published: (2014-08-01)

Detection of interleukin-6 and interleukin-8 in serum from women with recurrent spontaneous abortion
by: Baghdad Science Journal
Published: (2010-09-01)

Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors
by: V. I. Petrov, et al.
Published: (2022-04-01)

Dynamics of modified cardiovascular risk factors in patients with rheumatoid arthritis on the background of 5-year therapy with an interleukin 6 receptor inhibitor
by: E. V. Gerasimova, et al.
Published: (2024-03-01)

Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3
by: Jialin Song, et al.
Published: (2025-07-01)

New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01)

СHARACTERISTICS OF THE HEART FATTY ACID-BINDING PROTEIN, INTERLEUKIN-6 AND INTERLEUKIN-8 AS ALTERNATIVE MARKERS OF DIABETIC NEPHROPATHY PROGRESSION IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
by: Yu. A. Ryzhikova, et al.
Published: (2015-10-01)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01)

The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
by: Cheng-Der Liu, et al.
Published: (2021-01-01)

Targeted regulatory T cell activation by site-specific PEGylated interleukin-2 mitigates autoimmune inflammation
by: Masahiro Ikeda, et al.
Published: (2025-12-01)

Dynamics of traditional modifiable risk factors, total cardiovascular risk, and structural changes of carotid arteries in patients with rheumatoid arthritis on long-term interleukin-6 receptor antagonist treatment
by: E. V. Gerasimova, et al.
Published: (2021-03-01)

The effect of eight-week yoga training on serum levels of interleukin 6, interleukin 10, tumor necrosis factor alpha and body composition in women with multiple sclerosis
by: Elham Maddah, et al.
Published: (2024-08-01)

INTERLEUKIN 33 AND FIBROSIS: PATHOGENESIS UPDATED
by: E. G. Uchasova, et al.
Published: (2018-06-01)

The role of interleukin 1 in the development of human diseases
by: E. L. Nasonov
Published: (2019-04-01)

Research advances in understanding the role of interleukin-22 in renal disease
by: Zhao Dan, et al.
Published: (2022-01-01)

Plasma Proteomic Markers of Interleukin-1β Pathway Associated with Incident Age-Related Macular Degeneration in Persons with AIDS
by: Peter W. Hunt, MD, et al.
Published: (2025-09-01)

EXPRESSION OF PATTERN-RECOGNIZING RECEPTORS AND TRANSCRIPTIONAL REGULATORS OF T HELPER CELL DIFFERENTIATION BY INTESTINAL LYMPHOCYTES IN EXPERIMENTAL ILEITIS AND UPON ADMINISTRATION OF SIMVASTATIN AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
by: A. S. Zherebiatiev, et al.
Published: (2015-04-01)

Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6
by: Evgeny L. Nasonov, et al.
Published: (2024-09-01)

N-acetylcysteine reduces the hepatic complications of social isolation stress through modulation of interleukin 1 and 6 gene expression and liver enzymes in mice
by: Javad Asgharzadeh, et al.
Published: (2025-07-01)

The Pivotal Role of Interleukin-17 in the Pathogenesis of Systemic Lupus Erythematosus
by: Duaa Sami Segatri, et al.
Published: (2025-06-01)

Salivary Interleukins as Non-Invasive Biomarkers for Psoriasis: Advances and Challenges in Diagnosis and Monitoring
by: Anna Sora, et al.
Published: (2025-06-01)

INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes
Published: (2016-09-01)

EXPRESSION DENSITY OF RECEPTORS TO IMMUNOREGULATORY MEDIATORS AS A MODULATING COMPONENT OF BIOLOGICAL EFFECTS OF MEDIATORS ON CELL. PART 1
by: S. V. Sennikov, et al.
Published: (2019-05-01)

Interleukin 8 Molecular Interplay in Allergic Rhinitis and Chronic Rhinosinusitis with Nasal Polyps: A Scoping Review
by: Romica Cergan, et al.
Published: (2025-03-01)

Expression of chicken interleukin-2 gene in Pichia methanolica
by: ZHOU Ji-yong, et al.
Published: (2003-07-01)

THE ROLE OF TUMOR NECROSIS FACTOR-α G–308A, INTERLEUKIN-1β C–511T AND INTERLEUKIN-10 G–1082A GENE POLYMORPHISMS IN THE DEVELOPMENT OF SLOWLYRESOLVED COURSE OF COMMUNITY-ACQUIRED PNEUMONIA
by: V. I. Sovalkin, et al.
Published: (2013-12-01)

Interleukins as one of possible markers for early diagnosis of viral hepatitis c at first year old children
by: T. A. Kirsanova
Published: (2014-09-01)

Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy
by: P. A. Shesternya, et al.
Published: (2024-10-01)

Serum Levels of IL-6 Type Cytokines and Soluble IL-6 Receptors in Active B-Cell Chronic Lymphocytic Leukemia and in Cladribine Induced Remission
by: T. Robak, et al.
Published: (1999-01-01)

To evaluate the role of interleukin-6 in alopecia areata
by: Sobia Wali Muhammad, et al.
Published: (2024-04-01)

Role of interleukin 1 in the development of atherosclerosis
by: E. L. Nasonov, et al.
Published: (2019-04-01)

Association of polymorphic markers in innate immunity receptor genes with the risk of primary adrenal insufficiency
by: N. D. Rasskazova, et al.
Published: (2025-06-01)